|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:bfsLayer
|
5
|
|
gptkbp:bfsParent
|
gptkb:Bausch_&_Lomb
|
|
gptkbp:acquisition
|
Acquired by Bausch Health Companies Inc.
Acquired several companies in eye care
|
|
gptkbp:awards
|
Various industry awards
|
|
gptkbp:brand
|
gptkb:Bausch_+_Lomb
|
|
gptkbp:ceo
|
gptkb:Joseph_C._Papa
|
|
gptkbp:community_involvement
|
gptkb:battle
|
|
gptkbp:competitors
|
gptkb:Essilor_Luxottica
gptkb:Johnson_&_Johnson_Vision
gptkb:Alcon
gptkb:Cooper_Vision
|
|
gptkbp:employees
|
Over 10,000
|
|
gptkbp:established
|
gptkb:19th_century
|
|
gptkbp:financial_products
|
Publicly traded financials available
|
|
gptkbp:focus
|
Eye health
|
|
gptkbp:focus_area
|
Vision care
|
|
gptkbp:founded
|
1853
|
|
gptkbp:founder
|
John Bausch
|
|
gptkbp:global_presence
|
gptkb:battle
|
|
gptkbp:headcount
|
Approximately 14,000
|
|
gptkbp:headquarters
|
gptkb:United_States
gptkb:Rochester,_New_York
Rochester, NY, USA
|
|
gptkbp:historical_event
|
Over 160 years of history.
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Bausch + Lomb Eye Technologies Inc.
|
|
gptkbp:industry
|
Healthcare
|
|
gptkbp:innovation
|
gptkb:battle
|
|
gptkbp:key_people
|
gptkb:Joseph_C._Papa
Other executives
|
|
gptkbp:market
|
Global
Significant in eye care
|
|
gptkbp:parent_company
|
gptkb:Bausch_Health_Companies_Inc.
|
|
gptkbp:partnerships
|
Various healthcare organizations
|
|
gptkbp:product_line
|
Pharmaceutical products
Surgical products
Vision care products
|
|
gptkbp:products
|
gptkb:Photographer
Pharmaceuticals
Ophthalmic surgical products
|
|
gptkbp:research_and_development
|
gptkb:battle
|
|
gptkbp:revenue
|
$3 billion (2020)
|
|
gptkbp:subsidiary
|
Bausch + Lomb Australia Pty Ltd.
Bausch + Lomb Canada Inc.
Bausch + Lomb UK Ltd.
|
|
gptkbp:sustainability_initiatives
|
gptkb:battle
|
|
gptkbp:traded_on
|
NYSE: BHC
|
|
gptkbp:trademark
|
Bausch + Lomb logo
|
|
gptkbp:type
|
gptkb:football_club
|
|
gptkbp:website
|
www.bausch.com
|